Brief: Arch Therapeutics Receives Marketing Clearance From The US FDA Related To The AC5 Topical Gel Supply Chain
23/03/2020 11:54
March 23 (Reuters) - Arch Therapeutics Inc ARTH.PK :
* ARCH THERAPEUTICS RECEIVES MARKETING CLEARANCE FROM THE US
FDA
RELATED TO THE AC5® TOPICAL GEL SUPPLY CHAIN
Source text for Eikon: ID:nGNXK1qDy
Further company coverage: ARTH.PK
(((Reuters.Briefs@thomsonreuters.com);))
Recent news on Arch Therapeutics
See all newsBrief: Arch Therapeutics Announces Intent To Uplist From OTC To National Exchange
Brief: Arch Therapeutics Raises Approximately $3.5 Million In Convertible Note Financing
Brief: Arch Raises About $1.1 Mln With Convertible Note Issuance
Brief: Arch Therapeutics Receives Marketing Clearance From The US FDA Related To The AC5 Topical Gel Supply Chain
Brief: Arch Therapeutics Withdraws 510(K) With Plans To Resubmit After Further Discussions With FDA